View Author
patient virus infection study hiv -2 therapy plasma count response individual level treatment disease group variant coreceptor number analysis netherland concentration hepatitis antiretroviral vaccination hiv -2 infection baseline table hiv-infected patients result hiv -2 variants hiv-infected antiretroviral therapy blood signi immunodeficiency effect tissue mutation incph coreceptor usage resistance receptor ficiency hiv infection clone usage t-cell control vaccine month signi ficantly replication sample value chemokine difference hbsag assay population follow-up virol rotterdam portal haart combination hiv -2-infected individuals liver atazanavir didanosine university sequence immunode ratio lymphoid virological strain nvp therapy 2-1 t cells disease progression trial
10 Most Recent Publications
|
Deep sequencing does not reveal additional transmitted mutations in patients diagnosed with HIV-1 variants with single nucleoside reverse transcriptase inhibitor resistance mutations
(Article)
Pingen, M. Ende, M.E. van der Wensing, A.M.J. El Barzouhi, A. Simen, B. Schutten, M. Boucher, C.A.B. |
2013-03-01
|
|
Long-term response rates of successful hepatitis B vaccination in HIV-infected patients
(Article)
Lopes, V.B. Hassing, R.J. Vriessluijs, T.E.M.S. de El Barzouhi, A. Hansen, B.E. Schutten, M. Man, R.A. de Ende, M.E. van der |
2013-02-04
|
|
Therapy failure resulting from superinfection by a drug-resistant HIV variant
(Article)
Pingen, M. Nouwen, J.L. Schutten, M. Boucher, C.A.B. Dinant, S. Albert, J. Mild, M. Brodin, J. Simen, B.B. Walsh, S. Kayser, M. Ende, M.E. van der |
2012-12-01
|
|
Photodynamic therapy with systemic meta-tetrahydroxyphenylchlorin in the treatment of anal intraepithelial neoplasia, grade 3
(Article)
Snoek, E.M. van der Hollander, J.C. den Aans, J.B. Sterenborg, H.J.C.M. Ende, M.E. van der Robinson, D.J. |
2012-10-01
|
|
Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension
(Article)
Schouten, J.N. Ende, M.E. van der Koëter, T. Rossing, H.H.M. Komuta, M. Verheij, J. Valk, M. van der Hansen, B.E. Janssen, H.L.A. |
2012-09-17
|
|
Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension
(Article)
Schouten, J.N. Ende, M.E. van der Koëter, T. Rossing, H.H.M. Komuta, M. Verheij, J.B. Valk, M. van der Hansen, B.E. Janssen, H.L.A. |
2012-09-17
|
|
Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIV
(Article)
Zoutendijk, R. Zaaijer, H.L. Janssen, H.L.A. Vries-Sluijs, T.E.M.S. de Reijnders, J.G.P. Mulder, J. Kroon, F.P. Eijk, A.C. van der Sonneveld, M.J. Man, R.A. de Ende, M.E. van der |
2012-09-15
|
|
Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 Is associated with high CD4+ T cell counts in viremic HIV-2 infection
(Article)
Khalid, M. Yu, H. Osterhaus, A.D.M.E. Kirchhoff, F. Sauter, D. Usmani, S.M. Schmokel, J. Feldman, E.J. Gruters, R.A. Ende, M.E. van der Geyer, M. Rowland-Jones, S.L. |
2012-05-01
|
|
A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption
(Article)
Allard, S.D. Keersmaecker, B. de Padmos, I. Thielemans, K. Osterhaus, A.D.M.E. Lacor, P. Ende, M.E. van der Aerts, J.L. Baalen, C.A. van Gruters, R.A. Goede, A.L. de Verschuren, E.J. Koetsveld, J. Reedijk, M.L. Wylock, C. Beyer, W.E.Ph. Eilers, P.H. Corthals, J. |
2012-03-01
|
|
Current and future applications of dried blood spots in viral disease management
(Article)
Snijdewind, I.J.M. Kampen, J.J.A. van Fraaij, P.L.A. Ende, M.E. van der Osterhaus, A.D.M.E. Gruters, R.A. |
2012-03-01
|
